Table 2. Comparison between the Included and Excluded Characteristics of the Subjects in Different Treatment Groupsa.
| Variable | Group A | Group B | Group C | Group D | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Included | Excluded | P value | Included | Excluded | P value | Included | Excluded | P value | Included | Excluded | P value | |
| No. of patients in subgroup | 34 | 15 | - | 89 | 43 | - | 96 | 43 | - | 82 | 40 | - |
| Male sex | 18 (52.9) | 10 (66.7) | 0.533 | 42 (47.2) | 20 (46.5) | 1.000 | 36 (37.3) | 16 (37.2) | 1.000 | 43 (57.3) | 22 (55.0) | 0.852 |
| Age, yr | 57.8±6.9 | 58.1±7.2 | 0.891 | 60.5±10.8 | 57.6±9.4 | 0.014 | 59.1±10.9 | 56.8±9.1 | 0.231 | 57.3±15.2 | 60.1±14.3 | 0.330 |
| Caucasian race | 34 (100) | 15 (100) | 1.000 | 89 (100) | 43 (100) | 1.000 | 96 (100) | 43 (100) | 1.000 | 82 (100) | 40 (100) | 1.000 |
| HbA1c, % | 7.9±1.6 | 7.0±1.9 | 0.093 | 7.5±1.2 | 7.0±1.9 | 0.070 | 8.6±1.7 | 9.1±2.1 | 0.140 | 8.2±1.7 | 7.84±2.2 | 0.321 |
| BMI, kg/m2 | 29.8±2.7 | 28.8±3.1 | 0.258 | 30.7±3.1 | 31.7±3.7 | 0.110 | 31.1±3.2 | 29.9±4.1 | 0.061 | 32.5±3.8 | 31.06±4.9 | 0.080 |
| Duration of diabetes, yr | 5.92±1.3 | 6.63±1.9 | 0.140 | 7.16±2.3 | 8.01±2.9 | 0.070 | 8.25±2.9 | 7.73±3.1 | 0.340 | 6.82±1.8 | 7.31±2.21 | 0.201 |
Values are expressed as number (%) or mean±SD.
HbA1c, glycated hemoglobin; BMI, body mass index.
aGroup A (patients on metformin, glimepiride and insulin), B (patients on metformin and glimepiride), C (patients on metformin and insulin), and D (patients on insulin alone).